You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dent 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Huntington Disease Trial in Amherst (Tominersen 60 mg, Placebo, Tominersen 100 mg)

Recruiting
  • Huntington Disease
  • Tominersen 60 mg
  • +2 more
  • Amherst, New York
    Dent Neurological
Jan 30, 2023

Trigeminal Neuralgia Trial in United States (Rimegepant, Placebo)

Recruiting
  • Trigeminal Neuralgia
  • Gilbert, Arizona
  • +10 more
Dec 15, 2022

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting
  • Adenine Phosphoribosyltransferase Deficiency
  • +83 more
    • Bristol, South West, United Kingdom
      Zoe Plummer
    Sep 26, 2023

    Obesity, Overweight and Obesity Trial in United States (LY3305677, Placebo)

    Not yet recruiting
    • Obesity
    • Overweight and Obesity
    • Mesa, Arizona
    • +23 more
    Nov 6, 2023

    Migraine Trial in United States (AMG 334 Dose 1, AMG 334 Dose 2, AMG 334 Dose 3)

    Terminated
    • Migraine
    • AMG 334 Dose 1
    • +2 more
    • Little Rock, Arkansas
    • +13 more
    Feb 10, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

    Active, not recruiting
    • Primary Progressive Multiple Sclerosis
    • Secondary Progressive Multiple Sclerosis
    • ATA188
    • Placebo
    • La Jolla, California
    • +33 more
    Jul 21, 2022

    Focal Epilepsy Trial in United States (BHV-7000, Placebo)

    Not yet recruiting
    • Focal Epilepsy
    • Tucson, Arizona
    • +33 more
    Nov 22, 2023

    Prospective Research Rare Kidney Stones (ProRKS)

    Recruiting
    • Hyperoxaluria
    • +4 more
      • Birmingham, Alabama
      • +10 more
      Nov 10, 2022

      Myasthenia Gravis Trial in Canada, United States (RVT-1401, Placebo)

      Completed
      • Myasthenia Gravis
      • Mobile, Alabama
      • +19 more
      Oct 6, 2021

      Rare Kidney Stone Consortium Patient Registry

      Recruiting
      • Primary Hyperoxaluria
      • +3 more
        • Rochester, Minnesota
        • +3 more
        Aug 19, 2022

        Migraine Trial in United States (Rimegepant 75mg daily dosing, Rimegepant 75mg every other day dosing, Placebo comparator

        Recruiting
        • Migraine
        • Rimegepant 75mg daily dosing
        • +2 more
        • Tempe, Arizona
        • +55 more
        Jan 18, 2023

        Migraine Trial in United States (ABP-450)

        Enrolling by invitation
        • Migraine
        • Chandler, Arizona
        • +36 more
        Jul 22, 2022

        Subjective Tinnitus Trial in Worldwide (OTO-313, Placebo)

        Completed
        Has Results
        • Subjective Tinnitus
        • Fresno, California
        • +47 more
        Dec 13, 2022

        Partially Edentulous Maxilla, Partially Edentulous Mandible Trial in Bucharest (Full digital workflow, Partially digital

        Completed
        • Partially Edentulous Maxilla
        • Partially Edentulous Mandible
        • Full digital workflow
        • Partially digital workflow
        • Bucharest, Romania
        • +1 more
        Jul 13, 2020

        Parkinson Disease Trial in Worldwide (Placebo, PF-06649751 low dose (1 mg QD), PF-06649751 middle dose 1 (3 mg QD))

        Terminated
        Has Results
        • Parkinson Disease
        • Placebo
        • +4 more
        • Phoenix, Arizona
        • +56 more
        Oct 28, 2020

        Migraine Trial in Australia, Canada, United States (ABP-450, Placebo)

        Recruiting
        • Migraine
        • Chandler, Arizona
        • +62 more
        Jan 30, 2023

        Rare Kidney Stone Consortium Biobank

        Recruiting
        • Primary Hyperoxaluria
        • +3 more
          • Rochester, Minnesota
            Mayo Clinic
          Jul 8, 2021

          Alzheimer's Disease Neuroimaging Initiative 2

          Completed
          • Mild Cognitive Impairment (MCI)
          • +4 more
          • Birmingham, Alabama
          • +57 more
          Feb 11, 2022

          Depression Trial in Moldova, Republic of, Romania (JNJ-39393406, Placebo)

          Completed
          • Depression
          • Codru, Moldova, Republic of
          • +3 more
          May 20, 2020

          Suboptimally Controlled Participants Previously Taking Oral or

          Recruiting
          • Multiple Sclerosis
          • Cladribine Tablets
          • Cullman, Alabama
          • +66 more
          Nov 29, 2022

          Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol

          Recruiting
          • Mild Cognitive Impairment (MCI)
          • Alzheimer's Disease (AD)
            • Birmingham, Alabama
            • +58 more
            Jun 15, 2022

            ALS Trial in Worldwide (MT-1186, Placebo)

            Recruiting
            • ALS
            • Phoenix, Arizona
            • +94 more
            Dec 9, 2022

            Epilepsy, Seizures, Drug Resistant Epilepsy Trial in Worldwide (Vagus Nerve Stimulation (VNS) Therapy)

            Active, not recruiting
            • Epilepsy
            • +2 more
            • Vagus Nerve Stimulation (VNS) Therapy
            • Grand Junction, Colorado
            • +62 more
            Aug 20, 2021

            Migraine Trial in Worldwide (Erenumab Dose 1, Erenumab Dose 2, Erenumab Dose 3)

            Recruiting
            • Migraine
            • Erenumab Dose 1
            • +3 more
            • Aurora, Colorado
            • +88 more
            Feb 1, 2023

            Migraine Trial in Worldwide (Erenumab Dose 1, Erenumab Dose 2, Erenumab Dose 3)

            Recruiting
            • Migraine
            • Erenumab Dose 1
            • +3 more
            • Aurora, Colorado
            • +82 more
            Dec 6, 2022